Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.93) by 4.15 percent. This is a 33 percent increase over losses of $(3.00) per share from the same period last year.
Comstock Files Grant Application for Cellulosic Fuels
Comstock Inc. (NYSE:LODE) ("Comstock" and the "Company") today announced its filing of a grant application with the U.S. Department of Energy ("DOE") to build a pre-pilot scale system to